Global mRNA Market Size, Share, and Growth & Trends Analysis Report by Product Type (Standard mRNA, Modified mRNA) By Application (Vaccines, Therapeutics, Others) By End-User (Hospitals, Research Institutes, Biotech & Pharmaceutical Companies): Regional Outlook, Growth Potential, and Segments Forecast 2024-2031

Loading...

Budget constraints? Get in touch with us for special pricing

Buying Options

Original price was: $6,000.00.Current price is: $5,100.00.
Original price was: $5,000.00.Current price is: $4,500.00.
Original price was: $4,000.00.Current price is: $3,800.00.
Loading...

Description

The Global mRNA Market size was USD 53.4 billion in 2023 and is expected to grow to USD 85.6 billion in 2031 with a CAGR of 19.6% during the forecast period from 2023 to 2030. 

Global mRNA Market: Overview

mRNA technology, which is essential in molecular biology, has increased in vaccination and medical studies. Biology advancements, bigger R&D expenditure, and an appetite for advance therapies all drive market growth. Moderna Pharmaceuticals and BioNTech/Pfizer are the industry leaders for mRNA COVID-19 vaccines. Moderna studies mRNA vaccines for a variety of disorders, whereas BioNTech concentrates on infectious illnesses and cancers. Initiatives such as the National Institutes of Health (NIH) and government collaborations in the United States and Canada promote academic research and manufacturing. Associations with Pfizer, BioNTech, Sanofi SA, Translate Bio, GSK, and CureVac show the industry’s overall commitment to mRNA technology.

Global mRNA Market: Covid-19 Impact

The COVID-19 pandemic has spurred global interest in mRNA technology, primarily through mRNA-based vaccines and therapies. Rapid development of COVID-19 vaccines by companies like Moderna and BioNTech/Pfizer has demonstrated mRNA’s effectiveness. Strong government funding, exemplified by initiatives such as the US National Biotechnology and Biomanufacturing Plan and Canadian partnerships, has propelled the sector forward. With over $5 billion invested in mRNA treatments in 2020 and expanding clinical trials, partnerships, and promising therapeutic advancements, the future of mRNA technology appears bright.

Global mRNA Market: Growth Drivers

  • Rapid Vaccine Development:

mRNA technology offers a fast and flexible foundation for vaccine creation, allowing unparalleled rapidity in the manufacturing of vaccines against novel illnesses that are infectious. The commercialization of mRNA-based COVID-19 vaccines underscored that technology’s capacity to revolutionise vaccine development while tackling global health issues.

  • Advancements in Therapeutics:

mRNA-based therapies show promise in addressing a variety of ailments, include cancer, respiratory infections, and genetic disorders. Ongoing efforts to conduct research and development are aimed at leveraging mRNA technology to provide novel drugs with higher safety and effectiveness features, hence improving market growth.

  • Investment in Biotechnology:

Growing investment in biotechnology R&D, in addition to federal support for mRNA technology, have contributed to progress in the sector. Biotech and pharmaceutical companies are broadening their mRNA portfolios and expanding into production infrastructure to meet increasing demand for mRNA products, resulting in market expansion.

Global mRNA Market: Restraining Factors

  • Regulatory Challenges:

The environment of regulation for mRNA products is evolving, posing obstacles for market participants in terms of getting approvals and bargaining complex legal processes. Regulatory uncertainties and burdensome standards may impede wider installation of mRNA technology, particularly in certain places.

  • Manufacturing Complexity:

The manufacturing process of mRNA-based medications and vaccines is complicated, needing specialised equipment and expertise. Scaling up production facilities to satisfy global demand presents problems regarding of scalability, control of quality, and supply chain administration, thereby impeding the expansion of the market.

Global mRNA Market:  Opportunity Factors

  • Expanded Applications:

Because of its adaptability, mRNA technology may be used for medicines, testing, and research in alongside vaccinations. Expanding the range of mRNA-based therapeutics in various therapeutic areas provides customers for market expansion as well as creativity.

  • Emerging Markets:

The increasing use of mRNA technology in developing countries, fuelled by increased healthcare expansion, rising biomedical investment, and growing pharmaceutical markets, offers considerable growth potential for market players. Emerging economies offer untapped possibilities for the use of mRNA products, particularly in vaccine development and controlling diseases.

Global mRNA Market: Challenges

  • Delivery Challenges:

The effective distribution of molecules of mRNA to target cells remains an essential problem in the creation of mRNA-based therapies. Addressing intracellular delivery challenges such as mRNA stability, intracellular absorption, and immunogenicity is crucial to improving the effectiveness of therapy and realising mRNA technology’s maximum potential.

Global mRNA Market: Segmentation

Based on Product Type: The market is segmented into Standard mRNA, Modified mRNA.

Based on Application: The market is segmented into Vaccines, Therapeutics, Others.

Based on End User: Hospitals, Research Institutes, Biotech & Pharmaceutical Companies

Based on Region: The market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is the largest market for nuclear power, driven by growing energy demand and government support for nuclear energy projects.

Global mRNA Market: Regional Insights

  • North America:

The North American mRNA market is established and because of tight sanitation standards, significant building, as well as enormous occurrences. The United States and Canada are major players. Assistance from the government, such as NIH funds, promotes mRNA research. The two governments encourage indigenous production, resulting in growth in markets. The success of the COVID-19 vaccine has caused an upsurge in clinical studies, with a CAGR of more than 60% from 2017 to 2021. This expansion reflects an increasing amount of uses for mRNA technology in medical.

  • Europe:

The mRNA market in Europe flourishes due to tight environmental restrictions, the development of sustainable sanitation practices, and an established tourism industry. Germany, the UK, and France are among the biggest nations. BioNTech, CureVac, and Moderna are promoting innovation. Collaborations between biotechnology and pharmaceutical companies accelerate development and research, thereby reinforcing Europe’s dominance in the mRNA market.

  • Asia Pacific:

The Asia Pacific region is witnessing rapid urbanization, infrastructure development, and rising disposable income levels, driving the demand for portable toilets. Emerging economies such as China, India, and Southeast Asian countries offer substantial growth opportunities for market players.

Global mRNA Market: Competitive Landscape

Moderna, BioNTech SE, CureVac, Translate Bio, Arcturus Therapeutics, eTheRNA Immunotherapies, Ethris GmbH, Novartis AG, Pfizer Inc., Sanofi SA, Roche Holding AG.

Global mRNA Market: Recent Developments

  • March 26, 2024: Moderna, Inc. announced that mRNA-1283, the Company’s next-generation COVID-19 vaccine, has successfully met the primary endpoints of its Phase 3 clinical trial, demonstrating a higher immune response against SARS-CoV-2 when compared to mRNA-1273.222, Moderna’s licensed COVID-19 vaccine.
  • May 29, 2024: BioNTech SE and the Coalition for Epidemic Preparedness Innovations (“CEPI”) are expanding their strategic partnership to contribute to building a sustainable and resilient end-to-end African vaccine ecosystem.

Table of Content

CHAPTER 1: EXECUTIVE SUMMARY
1.1. Summary
CHAPTER 2: RESEARCH METHODOLOGY
2.1. Research Process
2.2. Primary Research
2.3. Secondary Research
2.4. Market Size Estimation
2.5. Research Methodology
2.6. Analyst Tools/Models/Techniques
2.6.1. Notations
2.7. Market Scope & Segmentation
2.8. Currency & Pricing Considered
CHAPTER 3: MARKET TRENDS
3.1. Introduction
3.2. Drivers
3.2.1. Rapid Vaccine Development
3.3. Restraints
3.3.1. Regulatory Challenges
3.4. Opportunities
3.4.1. Expanded Applications
3.5. Challenges
3.5.1. Delivery Challenges
3.6. Investment Feasibility Analysis
3.7. Latest Trends
CHAPTER 4: MARKET ASSESSMENT
4.1. Porters Five Forces Analysis
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitute
4.1.5. Intensity of Competitive Rivalry
4.2. Value Chain Analysis
4.3. Market Share Analysis
4.4. Impact of Key Regulations on the Market
4.5. SWOT Analysis
4.6. PESTEL Analysis
4.7. Patent Analysis
4.7.1. By Product Type
4.7.2. By Application
4.7.3. By End User
4.7.4. By Region
4.8. Roadmap Development
4.9. Market Lineage Outlook
4.9.1. Parent Market Outlook
4.9.2. Ancillary Market Outlook
CHAPTER 5: IMPACT OF RECESSION ON THE MARKET
5.1. Introduction
5.1.1. Short Term Impact
5.1.2. Long Term Impact
CHAPTER 6: GLOBAL MRNA MARKET, BY PRODUCT TYPE
6.1. Introduction
6.1.1. Market Size & Forecast
6.1.2. Global MRNA Market Share, by Product Type-2023 and 2031 (%)
6.2. STANDARD MRNA
6.2.1. Key market Trends, Growth Factors, and Opportunities
6.2.2. Market Size and Forecast, by Regions
6.3. MODIFIED MRNA
6.3.1. Key market Trends, Growth Factors, and Opportunities
6.3.2. Market Size and Forecast, by Regions
CHAPTER 7: GLOBAL MRNA MARKET, BY APPLICATION
7.1. Introduction
7.1.1. Market Size & Forecast
7.1.2. Global MRNA Market Share, APPLICATION -2023 and 2031 (%)
7.2. VACCINES
7.2.1. Key market Trends, Growth Factors, and Opportunities
7.2.2. Market Size and Forecast, by Regions
7.3. THERAPEUTICS
7.3.1. Key market Trends, Growth Factors, and Opportunities
7.3.2. Market Size and Forecast, by Regions
7.4. OTHERS
7.4.1. Key market Trends, Growth Factors, and Opportunities
7.4.2. Market Size and Forecast, by Regions
CHAPTER 8: GLOBAL MRNA MARKET, BY END USER
8.1. Introduction
8.1.1. Market Size & Forecast
8.1.2. Cloud Storage Market Share, by END USER -2023 and 2031 (%)
8.2. HOSPITALS
8.2.1. Key market Trends, Growth Factors, and Opportunities
8.2.2. Market Size and Forecast, by Regions
8.3. RESEARCH INSTITUTES
8.3.1. Key market Trends, Growth Factors, and Opportunities
8.3.2. Market Size and Forecast, by Regions
8.4. BIOTECH
8.4.1. Key market Trends, Growth Factors, and Opportunities
8.4.2. Market Size and Forecast, by Regions
8.5. PHARMACEUTICAL COMPANIES
8.5.1. Key market Trends, Growth Factors, and Opportunities
8.5.2. Market Size and Forecast, by Regions
CHAPTER 9: GLOBAL MRNA MARKET, BY REGION
9.1. Introduction
9.1.1. Market Size & Forecast
9.1.2. Global MRNA Market Share, by REGION -2023 and 2031 (%)
9.2. NORTH AMERICA
9.2.1. Key market Trends, Growth Factors, and Opportunities
9.2.2. Market Size and Forecast, by Regions
9.3. EUROPE
9.3.1. Key market Trends, Growth Factors, and Opportunities
9.3.2. Market Size and Forecast, by Regions
9.4. ASIA PACIFIC
9.4.1. Key market Trends, Growth Factors, and Opportunities
9.4.2. Market Size and Forecast, by Regions
CHAPTER 10: NORTH AMERICA MARKET ANALYSIS
10.1. Introduction
10.2. MRNA Market by Country
10.3. North America MRNA Market by Country, USD Million 2019-2031
10.3.1. Market Size & Forecast, By PRODUCT TYPE
10.3.2. Market Size & Forecast, by APPLICATION
10.3.3. Market Size & Forecast, by END USER
10.3.4. Market Size & Forecast, by REGION
10.4. U.S.
10.4.1. Market Size & Forecast, By PRODUCT TYPE
10.4.2. Market Size & Forecast, by APPLICATION
10.4.3. Market Size & Forecast, by END USER
10.4.4. Market Size & Forecast, by REGION
10.5. Canada
10.5.1. Market Size & Forecast, By PRODUCT TYPE
10.5.2. Market Size & Forecast, by APPLICATION
10.5.3. Market Size & Forecast, by END USER
10.5.4. Market Size & Forecast, by REGION
CHAPTER 11: EUROPE MARKET ANALYSIS
11.1. Introduction
11.2. MRNA Market by Country
11.3. Europe MRNA Market by Country, USD Million 2019-2031
11.3.1. Market Size & Forecast, By PRODUCT TYPE
11.3.2. Market Size & Forecast, by APPLICATION
11.3.3. Market Size & Forecast, by END USER
11.3.4. Market Size & Forecast, by REGION
11.4. Germany
11.4.1. Market Size & Forecast, By PRODUCT TYPE
11.4.2. Market Size & Forecast, by APPLICATION
11.4.3. Market Size & Forecast, by END USER
11.4.4. Market Size & Forecast, by REGION
11.5. France
11.5.1. Market Size & Forecast, By PRODUCT TYPE
11.5.2. Market Size & Forecast, by APPLICATION
11.5.3. Market Size & Forecast, by END USER
11.5.4. Market Size & Forecast, by REGION
11.6. U.K.
11.6.1. Market Size & Forecast, By PRODUCT TYPE
11.6.2. Market Size & Forecast, by APPLICATION
11.6.3. Market Size & Forecast, by END USER
11.6.4. Market Size & Forecast, by REGION
11.7. Italy
11.7.1. Market Size & Forecast, By PRODUCT TYPE
11.7.2. Market Size & Forecast, by APPLICATION
11.7.3. Market Size & Forecast, by END USER
11.7.4. Market Size & Forecast, by REGION
11.8. Spain
11.8.1. Market Size & Forecast, By PRODUCT TYPE
11.8.2. Market Size & Forecast, by APPLICATION
11.8.3. Market Size & Forecast, by END USER
11.8.4. Market Size & Forecast, by REGION
11.9. Benelux
11.9.1. Market Size & Forecast, By PRODUCT TYPE
11.9.2. Market Size & Forecast, by APPLICATION
11.9.3. Market Size & Forecast, by END USER
11.9.4. Market Size & Forecast, by REGION
11.10. Rest of Europe
11.10.1. Market Size & Forecast, By PRODUCT TYPE
11.10.2. Market Size & Forecast, by APPLICATION
11.10.3. Market Size & Forecast, by END USER
11.10.4. Market Size & Forecast, by REGION
CHAPTER 12: ASIA-PACIFIC MARKET ANALYSIS
12.1. Introduction
12.2. MRNA Market by Country
12.3. Asia Pacific Cloud Storage Market by Country, USD Million 2019-2031
12.3.1. Market Size & Forecast, By PRODUCT TYPE
12.3.2. Market Size & Forecast, by APPLICATION
12.3.3. Market Size & Forecast, by END USER
12.3.4. Market Size & Forecast, by REGION
12.4. China
12.4.1. Market Size & Forecast, By PRODUCT TYPE
12.4.2. Market Size & Forecast, by APPLICATION
12.4.3. Market Size & Forecast, by END USER
12.4.4. Market Size & Forecast, by REGION
12.5. India
12.5.1. Market Size & Forecast, By PRODUCT TYPE
12.5.2. Market Size & Forecast, by APPLICATION
12.5.3. Market Size & Forecast, by END USER
12.5.4. Market Size & Forecast, by REGION
12.6. Japan
12.6.1. Market Size & Forecast, By PRODUCT TYPE
12.6.2. Market Size & Forecast, by APPLICATION
12.6.3. Market Size & Forecast, by END USER
12.6.4. Market Size & Forecast, by REGION
12.7. Australia
12.7.1. Market Size & Forecast, By PRODUCT TYPE
12.7.2. Market Size & Forecast, by APPLICATION
12.7.3. Market Size & Forecast, by END USER
12.7.4. Market Size & Forecast, by REGION
12.8. South Korea
12.8.1. Market Size & Forecast, By PRODUCT TYPE
12.8.2. Market Size & Forecast, by APPLICATION
12.8.3. Market Size & Forecast, by END USER
12.8.4. Market Size & Forecast, by REGION
12.9. Souethest Asia
12.9.1. Market Size & Forecast, By PRODUCT TYPE
12.9.2. Market Size & Forecast, by APPLICATION
12.9.3. Market Size & Forecast, by END USER
12.9.4. Market Size & Forecast, by REGION
12.10. Rest of Asia Pacific
12.10.1. Market Size & Forecast, By PRODUCT TYPE
12.10.2. Market Size & Forecast, by APPLICATION
12.10.3. Market Size & Forecast, by END USER
12.10.4. Market Size & Forecast, by REGION
CHAPTER 13: LATIN AMERICA AND THE CARIBBEAN MARKET ANALYSIS
13.1. Introduction
13.2. MRNA Market by Country
13.3. Latin America MRNA Market by Country, USD Million 2019-2031
13.3.1. Market Size & Forecast, By PRODUCT TYPE
13.3.2. Market Size & Forecast, by APPLICATION
13.3.3. Market Size & Forecast, by END USER
13.3.4. Market Size & Forecast, by REGION
13.4. Brazil
13.4.1. Market Size & Forecast, By PRODUCT TYPE
13.4.2. Market Size & Forecast, by APPLICATION
13.4.3. Market Size & Forecast, by END USER
13.4.4. Market Size & Forecast, by REGION
13.5. Mexico
13.5.1. Market Size & Forecast, By PRODUCT TYPE
13.5.2. Market Size & Forecast, by APPLICATION
13.5.3. Market Size & Forecast, by END USER
13.5.4. Market Size & Forecast, by REGION
13.6. Rest of Latin America
13.6.1. Market Size & Forecast, By PRODUCT TYPE
13.6.2. Market Size & Forecast, by APPLICATION
13.6.3. Market Size & Forecast, by END USER
13.6.4. Market Size & Forecast, by REGION
CHAPTER 14: THE MIDDLE EAST AND AFRICA MARKET ANALYSIS
14.1. Introduction
14.2. MRNA Market by Country
14.3. MEA MRNA Market by Country, USD Million 2019-2031
14.3.1. Market Size & Forecast, By PRODUCT TYPE
14.3.2. Market Size & Forecast, by APPLICATION
14.3.3. Market Size & Forecast, by END USER
14.3.4. Market Size & Forecast, by REGION
14.4. South Africa
14.4.1. Market Size & Forecast, By PRODUCT TYPE
14.4.2. Market Size & Forecast, by APPLICATION
14.4.3. Market Size & Forecast, by END USER
14.4.4. Market Size & Forecast, by REGION
14.5. Saudi Arabia
14.5.1. Market Size & Forecast, By PRODUCT TYPE
14.5.2. Market Size & Forecast, by APPLICATION
14.5.3. Market Size & Forecast, by END USER
14.5.4. Market Size & Forecast, by REGION
14.6. UAE
14.6.1. Market Size & Forecast, By PRODUCT TYPE
14.6.2. Market Size & Forecast, by APPLICATION
14.6.3. Market Size & Forecast, by END USER
14.6.4. Market Size & Forecast, by REGION
14.7. Rest of MEA
14.7.1. Market Size & Forecast, By PRODUCT TYPE
14.7.2. Market Size & Forecast, by APPLICATION
14.7.3. Market Size & Forecast, by END USER
14.7.4. Market Size & Forecast, by REGION
CHAPTER 15: COMPETITIVE LANDSCAPE
15.1. Introduction
15.2. Market Player Positioning, 2022
15.3. Company Evaluation Matrix
15.4. Product Mapping of Top 10 Player
15.5. Market Opportunities and Future Trends
15.6. Competitive Heatmap
15.7. Top Winning Growth Strategies
15.7.1. Major Growth Strategies
15.7.2. Expansion
15.7.3. Merger and Acquisition
15.7.4. Other Developments
CHAPTER 16: COMPANY PROFILES
16.1. MODERNA
16.1.1. Company Overview
16.1.2. Key Executives
16.1.3. Financial Overview
16.1.4. Business Product Type analysis
16.1.5. Product Portfolio
16.1.6. Key Strategic Developments
16.2. BIONTECH SE
16.3. CUREVAC
16.4. TRANSLATE BIO
16.5. ARCTURUS THERAPEUTICS
16.6. ETHERNA IMMUNOTHERAPIES
16.7. ETHRIS GMBH
16.8. NOVARTIS AG
16.9. PFIZER INC.
16.10. SANOFI SA
16.11. Roche Holding AG

Tables & Figures

LIST OF TABLES
Table 1. Global MRNA Market INDUSTRY SNAPSHOT, 2022-2031
Table 2. Global MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 3. Global MRNA Market STANDARD MRNA, BY REGION-2019-2031 (USD MILLION)
Table 4. Global MRNA Market MODIFIED MRNA, BY REGION-2019-2031 (USD MILLION)
Table 5. Global MRNA Market SHARE, by APPLICATION SIZE-2019-2031 (USD MILLION)
Table 6. Global MRNA Market VACCINES, BY REGION-2019-2031 (USD MILLION)
Table 7. Global MRNA Market THERAPEUTICS, BY REGION-2019-2031 (USD MILLION)
Table 8. Global MRNA Market OTHERS, BY REGION-2019-2031 (USD MILLION)
Table 9. Global MRNA Market SHARE, by END USER -2019-2031 (USD MILLION)
Table 10. Global MRNA Market HOSPITALS, BY REGION-2019-2031 (USD MILLION)
Table 11. Global MRNA Market RESEARCH INSTITUTES, BY REGION-2019-2031 (USD MILLION)
Table 12. Global MRNA Market BIOTECH, BY REGION-2019-2031 (USD MILLION)
Table 13. Global MRNA Market PHARMACEUTICAL COMPANIES, BY REGION-2019-2031 (USD MILLION)
Table 14. Global MRNA Market SHARE, REGION -2019-2031 (USD MILLION)
Table 15. Global MRNA Market FOR NORTH AMERICA, BY REGION-2019-2031 (USD MILLION)
Table 16. Global MRNA Market FOR EUROPE BY REGION-2019-2031 (USD MILLION)
Table 17. Global MRNA Market FOR ASIA PACIFIC BY REGION-2019-2031 (USD MILLION)
Table 18. NORTH AMERICA MRNA Market BY COUNTRY, USD MILLION 2019-2031
Table 19. NORTH AMERICA MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 20. NORTH AMERICA MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 21. NORTH AMERICA MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 22. NORTH AMERICA MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 23. U.S. MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 24. U.S. MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 25. U.S. MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 26. U.S. MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 27. CANADA MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 28. CANADA MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 29. CANADA MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 30. CANADA MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 31. EUROPE MRNA Market BY COUNTRY, USD MILLION 2019-2031
Table 32. EUROPE MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 33. EUROPE MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 34. EUROPE MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 35. EUROPE MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 36. GERMANY MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 37. GERMANY MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 38. GERMANY MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 39. GERMANY MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 40. FRANCE MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 41. FRANCE MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 42. FRANCE MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 43. FRANCE MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 44. UK MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 45. UK MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 46. UK MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 47. UK MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 48. ITALY MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 49. ITALY MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 50. ITALY MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 51. ITALY MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 52. SPAIN MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 53. SPAIN MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 54. SPAIN MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 55. SPAIN MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 56. BENELUX MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 57. BENELUX MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 58. BENELUX MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 59. BENELUX MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 60. REST OF EUROPE MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 61. REST OF EUROPE MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 62. REST OF EUROPE MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 63. REST OF EUROPE MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 64. ASIA PACIFIC MRNA Market BY COUNTRY, USD MILLION 2019-2031
Table 65. ASIA PACIFIC MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 66. ASIA PACIFIC MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 67. ASIA PACIFIC MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 68. ASIA PACIFIC MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 69. CHINA MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 70. CHINA MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 71. CHINA MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 72. CHINA MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 73. INDIA MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 74. INDIA MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 75. INDIA MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 76. INDIA MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 77. JAPAN MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 78. JAPAN MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 79. JAPAN MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 80. JAPAN MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 81. AUSTRALIA MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 82. AUSTRALIA MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 83. AUSTRALIA MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 84. AUSTRALIA MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 85. SOUTH KOREA MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 86. SOUTH KOREA MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 87. SOUTH KOREA MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 88. SOUTH KOREA MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 89. SOUETHEST ASIA MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 90. SOUETHEST ASIA MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 91. SOUETHEST ASIA MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 92. SOUETHEST ASIA MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 93. REST OF ASIA PACIFIC MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 94. REST OF ASIA PACIFIC MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 95. REST OF ASIA PACIFIC MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 96. REST OF ASIA PACIFIC MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 97. LATIN AMERICA MRNA Market BY COUNTRY, USD MILLION 2019-2031
Table 98. LATIN AMERICA MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 99. LATIN AMERICA MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 100. LATIN AMERICA MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 101. LATIN AMERICA MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 102. BRAZIL MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 103. BRAZIL MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 104. BRAZIL MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 105. BRAZIL MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 106. MEXICO MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 107. MEXICO MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 108. MEXICO MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 109. MEXICO MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 110. REST OF LATIN AMERICA MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 111. REST OF LATIN AMERICA MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 112. REST OF LATIN AMERICA MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 113. REST OF LATIN AMERICA MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 114. MEA MRNA Market BY COUNTRY, USD MILLION 2019-2031
Table 115. MEA MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 116. MEA MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 117. MEA MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 118. MEA MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 119. SOUTH AFRICA MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 120. SOUTH AFRICA MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 121. SOUTH AFRICA MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 122. SOUTH AFRICA MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 123. SAUDI ARABIA MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 124. SAUDI ARABIA MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 125. SAUDI ARABIA MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 126. SAUDI ARABIA MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 127. UAE MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 128. UAE MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 129. UAE MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 130. UAE MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 131. REST OF MEA MRNA Market SHARE, by PRODUCT TYPE-2019-2031 (USD MILLION)
Table 132. REST OF MEA MRNA Market SHARE, by APPLICATION -2019-2031 (USD MILLION)
Table 133. REST OF MEA MRNA Market SHARE, by END USER – 2019-2031 (USD MILLION)
Table 134. REST OF MEA MRNA Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 135. KEY EXPANSIONS (2019-2022)
Table 136. KEY MERGERS AND ACQUISITION (2019-2022)
Table 137. OTHER KEY DEVELOPMENTS (2019-2022)

LIST OF FIGURES
Figure 1. REGIONAL ANALYSIS (2022 & 2031)
Figure 2. RESEARCH PROCESS
Figure 3. ANALYSIS FRAMEWORK
Figure 4. IMPACT OF KEY REGULATION ON THE MARKET
Figure 5. SWOT ANALYSIS
Figure 6. Global MRNA Market SHARE, by PRODUCT TYPE -2023 & 2031 (USD MILLION)
Figure 7. Global MRNA Market , STANDARD MRNA -2019-2031 (USD MILLION)
Figure 8. Global MRNA Market , MODIFIED MRNA -2019-2031 (USD MILLION)
Figure 9. Global MRNA Market SHARE, by APPLICATION -2023 & 2031 (USD MILLION)
Figure 10. Global MRNA Market , VACCINES -2019-2031 (USD MILLION)
Figure 11. Global MRNA Market , THERAPEUTICS -2019-2031 (USD MILLION)
Figure 12. Global MRNA Market , OTHERS -2019-2031 (USD MILLION)
Figure 13. Global MRNA Market SHARE, by END USER -2023 & 2031 (USD MILLION)
Figure 14. Global MRNA Market , HOSPITALS -2019-2031 (USD MILLION)
Figure 15. Global MRNA Market , RESEARCH INSTITUTES -2019-2031 (USD MILLION)
Figure 16. Global MRNA Market , BIOTECH -2019-2031 (USD MILLION)
Figure 17. Global MRNA Market , PHARMACEUTICAL COMPANIES -2019-2031 (USD MILLION)
Figure 18. Global MRNA Market SHARE, by REGION -2023 & 2031 (USD MILLION)
Figure 19. Global MRNA Market , NORTH AMERICA -2019-2031 (USD MILLION)
Figure 20. Global MRNA Market , EUROPE -2019-2031 (USD MILLION)
Figure 21. Global MRNA Market , ASIA PACIFIC -2019-2031 (USD MILLION)
Figure 22. MARKET PLAYER POSITIONING, 2022
Figure 23. COMPANY EVALUATION MATRIX
Figure 24. PRODUCT MAPPING OF TOP 10 PLAYERS
Figure 25. COMPETITIVE HEATMAP OF KEY PLAYERS

Frequently Asked Questions (FAQ):

  • What are the main drivers behind the growth of the global mRNA market from 2024 to 2031?

    The growth is driven by rapid vaccine development, advancements in mRNA-based therapeutics, and increased investment in biotechnology.
  • How did the COVID-19 pandemic impact the mRNA market?

    The pandemic accelerated global interest and investment in mRNA technology, particularly through the rapid development and success of mRNA-based COVID-19 vaccines.
  • What are the primary challenges facing the mRNA market?

    Regulatory challenges and manufacturing complexity, including scaling up production and ensuring quality control, are significant hurdles.

Buying Options

Original price was: $6,000.00.Current price is: $5,100.00.
Original price was: $5,000.00.Current price is: $4,500.00.
Original price was: $4,000.00.Current price is: $3,800.00.